​

Funding Round

Series A - AUM Biosciences

Series A - AUM Biosciences

Investment Firm

Overview

AUM Biosciences is committed to addressing the unmet medical needs by developing innovative and affordable oncology therapeutics for Asia.

Announced Date

Oct 12, 2021

Funding Type

Series A

Highlights

Location

Asia

Social

Investor Lead

Everlife

Everlife

No designation

Participant Investors

3

Investor Name
Participant InvestorEverlife
Participant InvestorSPRIM
Participant InvestorThe Agency for Science, Technology and Research

Round Details and Background

AUM Biosciences raised $27000000 on 2021-10-12 in Series A

AUM Biosciences is committed to addressing the unmet medical needs by developing innovative and affordable oncology therapeutics for Asia.

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Dec 10, 2018
Seed Round - AUM Biosciences
-1.5M
Oct 12, 2021
Series A - AUM Biosciences
3-27.0M

Recent Activity

There is no recent news or activity for this profile.